Additionally, we found that PKM2 activity was higher in U251/TR cells than in U251 cells, and this difference was further intensified by hypoxia (Fig. 2J, K), indicating that PKM2 may play a critical role in hypoxia-induced TMZ resistance in glioma cells. This evidence concerns the gene PKM and central nervous system cancer.